We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.26B
AUM Growth
+$479M
Cap. Flow
+$608M
Cap. Flow %
14.26%
Top 10 Hldgs %
31.08%
Holding
808
New
118
Increased
74
Reduced
47
Closed
122

Sector Composition

Rank Sector Weight
1 Financials 25.33%
2 Technology 11.72%
3 Healthcare 8.7%
4 Industrials 6.46%
5 Consumer Discretionary 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.08T
$29.1M 0.68%
89,980
+9,680
+12% +$3.07M
REGN icon
27
Regeneron Pharmaceuticals
REGN
$72.9B
$28.9M 0.68%
41,991
+18,264
+77% +$11.5M
CF icon
28
CF Industries
CF
$19.6B
$27.8M 0.65%
+288,903
New +$28.2M
CMA
29
DELISTED
Comerica
CMA
$27.6M 0.65%
388,188
+94,896
+32% +$7.48M
ALIT icon
30
Alight
ALIT
$534M
$26.3M 0.62%
179,163
-2,678
-1% -$413K
PEN icon
31
Penumbra
PEN
$12.6B
$26.2M 0.61%
+137,968
New +$22.1M
ISRG icon
32
Intuitive Surgical
ISRG
$127B
$25.9M 0.61%
137,968
+85,816
+165% +$18.4M
AMZN icon
33
Amazon
AMZN
$2.44T
$25.7M 0.6%
+227,293
New +$28.7M
FSLR icon
34
First Solar
FSLR
$21.4B
$24.1M 0.57%
+182,579
New +$19.6M
IGV icon
35
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
$20.9M 0.49%
+418,035
New +$23.8M
MSFT icon
36
Microsoft
MSFT
$2.9T
$20.1M 0.47%
86,112
+34,786
+68% +$9.19M
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.64B
$19.9M 0.47%
180,060
+99,760
+124% +$10.1M
CVII
38
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$19.7M 0.46%
2,000,000
GHIX
39
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$19.4M 0.45%
2,000,000
UTHR icon
40
United Therapeutics
UTHR
$26.1B
$18.8M 0.44%
89,979
+15,890
+21% +$3.55M
RRX icon
41
Regal Rexnord
RRX
$12.5B
$18.8M 0.44%
+134,218
New +$18M
XOP icon
42
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$18.7M 0.44%
150,000
-50,000
-25% -$6.6M
BSX icon
43
Boston Scientific
BSX
$68.4B
$18.6M 0.44%
+479,888
New +$19.3M
PGR icon
44
Progressive
PGR
$128B
$18.3M 0.43%
157,683
+53,683
+52% +$6.46M
INSP icon
45
Inspire Medical Systems
INSP
$1.47B
$17.6M 0.41%
99,034
+25,098
+34% +$5.04M
GPN icon
46
Global Payments
GPN
$24.1B
$17.3M 0.41%
159,819
-16,156
-9% -$1.99M
TSM icon
47
TSMC
TSM
$1.94T
$17.2M 0.4%
250,732
+238,245
+1,908% +$19.7M
COF icon
48
Capital One
COF
$128B
$16.5M 0.39%
179,163
+32,524
+22% +$3.46M
PYPL icon
49
PayPal
PYPL
$50.3B
$15.7M 0.37%
+182,512
New +$16.2M
CONX
50
DELISTED
CONX Corp. Class A Common Stock
CONX
$15M 0.35%
1,500,000

Similar funds

Moore Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Moore Capital Management held 808 positions worth $4.26B, up 13% from $3.78B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Moore Capital Management deployed $608M of net new capital in Q3 2022, opening 118 new positions and adding to 74 existing holdings. Its largest new stake was Deere & Co: 90,049 shares worth $30.1M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Mastercard, an estimated $18.7M trimmed.

  • Moore Capital Management's largest Q3 2022 buy was Deere & Co: 90,049 shares worth $30.1M.
  • Moore Capital Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $127M increase.
  • Moore Capital Management's biggest Q3 2022 reduction was Mastercard, cutting an estimated $18.7M.
  • Moore Capital Management fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2022, selling an estimated $91.8M.
  • Moore Capital Management's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2022.
  • Moore Capital Management opened 118 new positions and closed 122 in Q3 2022.
  • Moore Capital Management's portfolio value rose 13% quarter-over-quarter to $4.26B.

Based on Moore Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.